In 1992, the American Cancer Society Foundation was created to allow the ACS to solicit contributions of more than $100,000 (page )
A close look at the heavy-hitters on the Foundation’s board made it clear what conflicts of interests were at play, and from where the Foundation expected its big contributions.
David R. Bethune, president of Lederle Laboratories, a multinational pharmaceutical company and a division of American Cyanamid Company. Bethune was also vice president of American Cyanamid, which made chemical fertilizers and herbicides while transforming itself into a full-fledged pharmaceutical company. In 1988, American Cyanamid introduced Novatrone, an anti-cancer drug, and subsequently announced that it would buy a majority of shares of Immunex, a cancer drug industry.
•Gordon Binder, CEO of Amgen, the world’s foremost biotechnology company, with over $1 billion in product sales in 1992. Amgen’s success rested almost exclusively on one product, Neupogen, administered to chemotherapy patients to stimulate production of their white blood cells. •Multimillionaire Irwin Beck, whose father, William Henry Beck, founded Beck’s Stores, the nation’s largest family-owned retail chain, which brought in revenues of $1.7 billion in 1993.
•Sumner M. Redstone, chairman of Viacom International Inc., a broadcasting, telecommunications, entertainment, and cable television corporation.